Innovation Pharmaceuticals IIPIX
13F holders, Q1 2024 (March 31)3holders
$0.01avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Innovation Pharmaceuticals I (IPIX) in their 13F filings. The largest holders were Able Wealth Management LLC ($796), Clear Point Advisors Inc. ($143) and Kingfisher Capital LLC ($0).
- Company
- Innovation Pharmaceuticals I
- CUSIP
- 45782D100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| Able Wealth Management LLC | 0.00% | Reduce -26.4% | 55,894 | $796 |
| Clear Point Advisors Inc. | 0.00% | No change | 10,000 | $143 |
| Kingfisher Capital LLC | 0.00% | No change | 11,000 | $0 |
"% of holder's portfolio" is IPIX's weight in each manager's 13F, not the share of Innovation Pharmaceuticals I the manager owns.